Allspring Global Investments Holdings LLC Acquires 46,370 Shares of Masimo Co. (NASDAQ:MASI)

Allspring Global Investments Holdings LLC increased its position in shares of Masimo Co. (NASDAQ:MASI - Free Report) by 1,936.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 48,764 shares of the medical equipment provider's stock after buying an additional 46,370 shares during the quarter. Allspring Global Investments Holdings LLC owned 0.09% of Masimo worth $8,220,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. ING Groep NV grew its position in Masimo by 143.3% during the third quarter. ING Groep NV now owns 240,900 shares of the medical equipment provider's stock worth $32,119,000 after buying an additional 141,900 shares in the last quarter. Westfield Capital Management Co. LP grew its position in Masimo by 23.2% during the third quarter. Westfield Capital Management Co. LP now owns 1,394,056 shares of the medical equipment provider's stock worth $185,869,000 after buying an additional 262,370 shares in the last quarter. National Bank of Canada FI boosted its holdings in Masimo by 195.6% during the third quarter. National Bank of Canada FI now owns 132,500 shares of the medical equipment provider's stock valued at $17,666,000 after purchasing an additional 87,675 shares in the last quarter. Lecap Asset Management Ltd. acquired a new stake in Masimo during the fourth quarter valued at approximately $1,607,000. Finally, Nisa Investment Advisors LLC boosted its holdings in Masimo by 16,740.0% during the fourth quarter. Nisa Investment Advisors LLC now owns 5,052 shares of the medical equipment provider's stock valued at $835,000 after purchasing an additional 5,022 shares in the last quarter. 85.96% of the stock is owned by institutional investors and hedge funds.

Masimo Price Performance

Shares of NASDAQ:MASI traded down $7.25 during trading on Friday, reaching $169.96. The stock had a trading volume of 603,597 shares, compared to its average volume of 474,198. Masimo Co. has a 52 week low of $101.61 and a 52 week high of $184.51. The business's 50-day moving average price is $172.90 and its 200 day moving average price is $151.29. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.01 and a quick ratio of 1.11. The stock has a market capitalization of $9.10 billion, a PE ratio of 117.21 and a beta of 1.02.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on MASI shares. Needham & Company LLC reaffirmed a "hold" rating on shares of Masimo in a report on Wednesday, January 22nd. Wells Fargo & Company lifted their price objective on Masimo from $171.00 to $193.00 and gave the company an "overweight" rating in a report on Wednesday, December 11th. Raymond James lifted their price objective on Masimo from $170.00 to $194.00 and gave the company an "outperform" rating in a report on Friday, December 27th. Stifel Nicolaus reaffirmed a "buy" rating and set a $190.00 price objective (up from $170.00) on shares of Masimo in a report on Friday, November 22nd. Finally, Piper Sandler lifted their price objective on Masimo from $180.00 to $210.00 and gave the company an "overweight" rating in a report on Wednesday, December 18th. Two analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $191.40.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.